12CATEDRAL-_-CHLAMYDIA

CHLAMYDIA PRESENTATION

Presented by: John Michael V. Catedral, DVM 3 - B

INTRODUCTION

  • Chlamydia trachomatis:

    • First described in historical records in Ebers papyrus (between 1553 and 1550 BC).

  • Definition:

    • Chlamydia refers to a genus of obligate intracellular pathogens.

    • Can only survive and reproduce within host cells.

  • Discovery:

    • Discovered in 1907 by Halberstaedter and von Prowazek in conjunctival scrapings from an infected orangutan.

  • Characteristics:

    • Responsible for various infectious diseases in animals and humans.

    • Divided into several species (e.g., Chlamydia psittaci, Chlamydia abortus).

TAXONOMY

  • Domain: Bacteria

  • Phylum: Chlamydia

  • Class: Chlamydiae

  • Order: Chlamydiales

  • Family: Chlamydiaceae

  • Genus: Chlamydia

  • Scientific Name: Chlamydia trachomatis

CLASSIFICATION

  • Genera Include:

    • Chlamydia, Chlamydophila, and Parachlamydia.

  • Notable Species:

    1. Chlamydia trachomatis: Causes trachoma, leading cause of preventable blindness, also genital infections.

    2. Chlamydophila pneumoniae: Causes respiratory infections in humans.

    3. Chlamydophila psittaci: Infects birds causing psittacosis.

    4. Chlamydophila felis: Causes conjunctivitis in cats.

CHLAMYDIAE

  • Small, spherical intracellular bacteria with unique developmental cycles.

  • Staining Methods:

    • Modified Ziehl-Neelsen, Giemsa.

  • Metabolism:

    • Cannot synthesize ATP; replicate only in living cells.

  • Cell Wall Composition:

    • Lack peptidoglycan; contain family-specific lipopolysaccharides.

  • Pathogenic Impact:

    • Cause diseases in respiratory, enteric, and reproductive tracts.

LIFE CYCLE OF CHLAMYDIAE

  • Stages:

    1. Elementary Body (EB) - Infectious stage that attaches and enters host cells.

    2. Reticulate Body (RB) - Replicative form that multiplies through binary fission.

    • Transition back to EB before host cell lysis.

  • Detailed Steps:

    1. Attachment & Entry: EB enters via endocytosis.

    2. Reticulate Body Formation: EB differentiates into RB once inside.

    3. Replication & Multiplication: RB multiplies within host cell.

    4. Assembly & Release: New EBs released to infect other cells.

DEVELOPMENTAL CYCLE

  • Characteristics of EBs:

    • Small (200-300 nm), metabolically inert.

    • Surrounded by a cytoplasmic membrane and an outer envelope with lipopolysaccharides.

  • Host Interaction:

    • Enter host cells by receptor-mediated endocytosis.

  • Conversion:

    • EBs reorganize into RBs, which reproduce and form inclusions within the cytoplasm.

  • Replication:

    • Continues for up to 72 hours, leading to cell lysis and release of infectious agents.

USUAL HABITAT

  • Infection often occurs in the gastrointestinal tract of animals.

  • Generally subclinical but can lead to prolonged intermittent shedding.

PATHOGENESIS AND TRANSMISSION

  • Infection Mechanism:

    • Infect epithelial cells; cause respiratory infections, abortions, conjunctivitis.

  • Transmission Routes:

    • Aerosol, direct contact with secretions, vertical transmission, environmental contamination.

PATHOGENESIS AND PATHOGENICITY

  • Infects over 450 species of birds and a large number of mammals, including humans.

  • Specific diseases often associated with particular hosts:

    • e.g., abortion in sheep caused by Chlamydophila abortus.

  • Infections often asymptomatic, localized, or persistent.

IMPORTANCE OF CHLAMYDIAE

  • Veterinary Pathogens:

    1. Chlamydia abortus: Ovine enzootic abortion.

    2. Chlamydia psittaci: Avian chlamydiosis.

    3. Chlamydia felis: Feline conjunctivitis.

  • Disease Manifestations:

    • Lead to abortion in livestock, respiratory infections in birds and mammals, conjunctivitis in cats.

DIAGNOSTIC PROCEDURES

  • Specimen Handling:

    • Place in suitable transport medium (e.g., SPG) and keep at 4°C.

  • Detection Methods:

    • Direct microscopy, ELISA, polymerase chain reaction, serological tests.

CLINICAL SIGNS IN ANIMALS

  • Common Signs:

    • Ruminants: abortion, conjunctivitis.

    • Birds: respiratory distress.

    • Cats: conjunctivitis and ocular discharge.

    • Dogs: respiratory infections, especially in puppies.

    • Rabbits: conjunctivitis.

CLINICAL INFECTIONS

  • Severity varies widely; conditions range from mild to severe.

  • Common Diseases:

    • Conjunctivitis, abortion, pneumonia.

  • Human infections from psittacine species termed psittacosis.

Ovine Enzootic Abortion (OEA)

  • Characteristics:

    • Caused by Chlamydophila abortus.

    • Significant economic impact due to reduced lamb production.

  • Infection Process:

    • Spread through infected animals or environments, leading to fetal infection and abortion.

ENZOOTIC ABORTION OF EWES (EAE)

  • Primarily affects intensively managed flocks, causing significant economic losses.

  • Source of Infection:

    • Generally coincides with sheep management practices, particularly during birthing seasons.

EPIDEMIOLOGY OF EAE

  • Introduced through infected animals.

  • Organisms shed in placentas and secretions remain viable in the environment.

PATHOGENESIS IN EAE

  • Infection detected around day 90 of gestation; affects placenta leading to inflammation.

  • Consequences of Infection:

    • Abortion can occur due to various factors including maternal-fetal exchange challenges.

CLINICAL SIGNS IN EAE

  • Characterized by abortion during late pregnancy or weak lamb births.

  • Affected animals often show no clinical signs beyond reproductive issues.

DIAGNOSIS OF EAE

  • Suggestive signs include necrotic placentitis; EBs detectable in placental smears.

  • Techniques include PCR, serological tests, and culture.

TREATMENT AND CONTROL

  • Antibiotics:

    • Long-acting oxytetracycline is effective.

  • Control Measures:

    • Isolation of aborted ewes, thorough cleaning, possible vaccination strategy.

FELINE CHLAMYDIOSIS

  • Caused by: Chlamydophila felis.

  • Symptoms:

    • Conjunctivitis, rhinitis, pneumonia; highly contagious among cats.

EPIDEMIOLOGY OF FELINE CHLAMYDIOSIS

  • Infects approximately 10% of unvaccinated cats; spreads via secretions.

  • More common in multi-cat households; stress can exacerbate shedding.

CLINICAL SIGNS IN FELINE CHLAMYDIOSIS

  • Characterized by conjunctival inflammation and potential secondary infections.

DIAGNOSIS OF FELINE CHLAMYDIOSIS

  • Methods:

    • Conjunctival swabs, PCR, serological tests.

TREATMENT AND CONTROL OF FELINE CHLAMYDIOSIS

  • Systemic antibiotic treatment recommended.

  • Vaccines available but do not prevent infection.

PSITTACOSIS (AVIAN CHLAMYDIOSIS)

  • Caused by Chlamydophila psittaci; zoonotic risks.

  • Primary infections in birds can lead to severe consequences.

SYMPTOMS IN BIRDS AND HUMANS

  • Birds: lethargy, respiratory distress; humans: flu-like symptoms, pneumonia.

AVIAN CHLAMYDIOSIS

  • Various serotypes impacting different avian species based on serological reactions.

EPIDEMIOLOGY OF AVIAN CHLAMYDIOSIS

  • Widespread susceptibility among wild and domestic birds; stress factors increase shedding.

CLINICAL SIGNS IN AVIAN CHLAMYDIOSIS

  • Generalized infections with gastrointestinal and respiratory symptoms.

DIAGNOSIS OF AVIAN CHLAMYDIOSIS

  • Detection methods include staining, ELISA, PCR, and culture.

TREATMENT AND CONTROL OF AVIAN CHLAMYDIOSIS

  • Tetracyclines are effective; proper husbandry reduces disease occurrence.

SPORADIC BOVINE ENCEPHALOMYELITIS

  • Neurological disease linked to infection with C. pecorum.

  • Symptoms: fever, incoordination, and can lead to high mortality.

POLYARTHRITIS IN LIVESTOCK

  • Inflammation of multiple joints, variable in causative chlamydial species.

  • Diagnosis and Treatment: Clinical exam and antibiotics.

ZOONOTIC RISKS OF CHLAMYDIAE

  • Chlamydial infections can transmit from animals to humans; good hygiene reduces risks.

DIAGNOSTIC METHODS OF CHLAMYDIAE

  • Clinical Methods: Observation, lab diagnosis (microscopy, PCR).

TREATMENT AND PREVENTION OF CHLAMYDIAE

  • Antibiotics (tetracyclines), potential vaccines, hygiene practices essential.

CONTROL AND PREVENTION STRATEGIES

  • Emphasizes biosecurity, quarantine, and vaccination where applicable.

THANK YOU